Biomarker Testing in Older Patients Treated for an Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer: The French ESME Real-Life Multicenter Cohort Experience

SIMPLE SUMMARY: Genomic and immunologic tumor biomarker testing has dramatically changed the prognosis of patients treated for advanced/metastatic non-squamous non-small-cell lung cancer (aNSCLC). In older patients, targeted therapy and immunotherapy appear attractive considering better tolerance an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamy, Tina, Cabarrou, Bastien, Planchard, David, Quantin, Xavier, Schneider, Sophie, Bringuier, Michael, Besse, Benjamin, Girard, Nicolas, Chouaid, Christos, Filleron, Thomas, Simon, Gaëtane, Baldini, Capucine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750267/
https://www.ncbi.nlm.nih.gov/pubmed/35008257
http://dx.doi.org/10.3390/cancers14010092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750267/
https://www.ncbi.nlm.nih.gov/pubmed/35008257
http://dx.doi.org/10.3390/cancers14010092

Ejemplares similares